<DOC>
	<DOCNO>NCT02782078</DOCNO>
	<brief_summary>Clindamycin rifampicin authorize osteoarticular infection treatment ( IDSA guideline ) interaction observe . The objective study evaluate quantify rifampicin interaction clindamycin</brief_summary>
	<brief_title>Pharmacological Interaction Rifampicin Clindamycin Staphylococcic Osteoarticular Infections</brief_title>
	<detailed_description>It could suggest modification recommend dos incitement antibiotic dosage . Thus , thesis antibiotic , association allow , could limit fluoroquinolones prescription avoid antibiotic resistance .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<criteria>osteoarticular infection staphylococcus sensibility erythromycin rifampicin pregnant minor dementia administration clindamycin rifampicin one month treatment enzymatic inductor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>osteoarticular infection</keyword>
	<keyword>rifampicin</keyword>
	<keyword>clindamycin</keyword>
	<keyword>enzymatic induction</keyword>
	<keyword>antibiotherapy resistance</keyword>
</DOC>